Clinical trial

SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy

NCT01959867

Study summary

ClinicalTrials.gov

SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention SurgiMend® PRS Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention No Intervention Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2017-01-01

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

SurgiMend® PRSDEVICE

No InterventionOTHER

Sponsors & collaborators

Integra LifeSciences Corporationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01959867 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.